ClinicalTrials.Veeva

Menu

The Nanowear Wearable Covid-19 Observational and Analysis Trend (NanoCOAT)

N

Nanowear

Status

Enrolling

Conditions

Covid19

Treatments

Device: Observational Study - no intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT04717024
NWCT20-SS-002

Details and patient eligibility

About

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has provided informed consent
  • Male or female over the age of 18 years
  • The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion criteria

  • Subject is unwilling or unable to wear the vest during hospitalization.
  • Subjects who are pregnant.
  • Subject is intubated or admitted to ICU
  • Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems